Coloplast A/S

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Coloplast A/S - overview

Established

1957

Location

-, -, Denmark

Primary Industry

Medical Devices & Equipment

About

Coloplast A/S is a Danish company dedicated to developing medical products that enhance the quality of life for individuals with intimate health needs, focusing on ostomy care, continence solutions, and wound management. Founded in 1957 in Denmark, Coloplast A/S specializes in creating products for intimate health. The company has evolved its business operations to focus on user-centered design in medical supplies. Christoph Süme is the current CEO, leading the company headquartered in Humlebæk, Denmark.


Coloplast Danmark A/S develops and markets a wide array of medical products designed to improve life quality for those with intimate health concerns. Key offerings include ostomy products, continence care solutions, and skin and wound care supplies, focusing on comfort and effective management. Their ostomy segment features innovative pouches that minimize leakage, while their continence care products address urinary and fecal incontinence for both patients and healthcare professionals. They primarily serve Denmark and Iceland, catering to healthcare providers and individual consumers.


In 2022, Coloplast reported a revenue of USD 3. 29 bn, with an EBITDA of USD 1. 07 bn, generated through direct sales and partnerships with healthcare providers, effectively targeting both B2B and consumer markets.


Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Supplies, Therapeutic Devices

Website

www.coloplast.dk

Verticals

HealthTech

Total Amount Raised

Subscriber access only

Coloplast A/S - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Coloplast A/S - financials

Fiscal Year EndedSep 30, 2011Sep 30, 2012Sep 30, 2013Sep 30, 2014Sep 30, 2015Sep 30, 2016Sep 30, 2017Sep 30, 2018Sep 30, 2019Sep 30, 2020Sep 30, 2021Sep 30, 2022Sep 30, 2023Sep 30, 2024
Revenue (USD)10,172,000,00011,023,000,00011,635,000,00012,428,000,00013,909,000,000-15,528,000,00016,449,000,00017,939,000,00018,544,000,00019,426,000,000---
% Revenue Growth (YoY)-8.4%5.6%6.8%11.9%--5.9%9.1%3.4%4.8%---
EBITDA (USD)3,108,000,0003,756,000,0004,160,000,0003,573,000,0002,020,000,000-5,635,000,0005,715,000,0005,807,000,0006,498,000,0006,947,000,000---
Operating Income (USD)2,581,000,0003,255,000,0003,672,000,0003,147,000,0001,535,000,000-5,024,000,0005,091,000,0005,156,000,0005,854,000,0006,155,000,000---
Operating Margin25.4%29.5%31.6%25.3%11.0%-32.4%31.0%28.7%31.6%31.7%---
% EBITDA Margin30.6%34.1%35.8%28.7%14.5%-36.3%34.7%32.4%35.0%35.8%---
NET Income (USD)1,819,000,0002,194,000,0002,711,000,0002,390,000,000899,000,000-3,797,000,0003,845,000,0003,873,000,0004,197,000,0004,825,000,000---
% Net Margin17.9%19.9%23.3%19.2%6.5%-24.5%23.4%21.6%22.6%24.8%---

Coloplast A/S - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Trade SaleCompletedAtos Medical AB-
Trade SaleCompletedLiberty Medical Holdings, LLC-
BuyoutCompletedAmoena-

Displaying 1 - 3 of 3

Coloplast A/S - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Coloplast A/S - key contacts

NamePositionStart DateEnd DateVcardBio 
Board MemberBM
Chairman of the BoardBM
Board MemberBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.